appwisp
  • App explorer
  • SDKs insights
  • API
  • Contact
  • About
  • API
  • Github
© 2025 appwisp.com

Blis: da consulta à entrega

com.canablis.paciente

View detailed information for Blis: da consulta à entrega — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
306.2K(306,206)
Rating
unknown
Released
unknown
Last updated
September 12, 2025
Category
Health & Fitness
Developer
Blis
Developer details

Name
Blis
E-mail
[email protected]
Website
unknown
Country
unknown
Address
unknown
Android SDKs

  • No items.
Blis: da consulta à entrega Header - AppWisp.com

Screenshots

Blis: da consulta à entrega Screenshot 1 - AppWisp.com
Blis: da consulta à entrega Screenshot 2 - AppWisp.com
Blis: da consulta à entrega Screenshot 3 - AppWisp.com
Blis: da consulta à entrega Screenshot 4 - AppWisp.com

Description

Blis has already helped more than 300,000 Brazilians to have legal access to products approved by ANVISA.

We are the only app that connects you from medical consultation to legal delivery of products authorized by ANVISA, all in one place.

01- Immediate Consultation (no need to schedule).

We connect you to specialist doctors who evaluate your clinical profile and, when indicated, can prescribe the most appropriate dosage.

02- Direct Import.
You import products directly from the best international brands, with total transparency and security.

03- ANVISA Authorization.
You receive your authorization through the app.

04- Home Delivery.
Follow the app and receive your products at home.

Download the Blis app and follow the step-by-step process safely.

Everything is legal, with a medical prescription, home delivery and full support.

-----------------------
If you have any questions or need to adjust the dosage, contact us via the app by clicking the HELP button.
-----------------------

•⁠ ⁠LEGAL INFORMATION •

The Blis app is part of the company BLIS COMERCIO E REPRESENTAÇÃO LTDA, CNPJ 51.888.558/0001-96, a company that helps Brazilian patients to follow the step-by-step instructions of RDC 660 - a resolution of the Ministry of Health - MS National Health Surveillance Agency - ANVISA, published in the DOU No. 62, of March 31, 2022 (official link below). https://www.in.gov.br/pt/web/dou/-/resolucao-rdc-n-660-de-30-de-marco-de-2022-389908959

All legal notices and terms and conditions of use of the blis app are presented throughout the app's journey. Please read them all carefully.